Mark Taylor, MD, FRCPsych, FRANZCP, Royal Edinburgh Hospital, Edinburgh, UK, and University of Queensland, Brisbane, Australia; Udayanga Perera, MBBS, MD, District General Hospital, Monaragala, Sri Lanka.
Br J Psychiatry. 2015 May;206(5):357-9. doi: 10.1192/bjp.bp.114.155945.
National Institute for Health and Care Excellence (NICE) clinical guideline (CG)178 was published in 2014. NICE guidelines occupy an important international position. We argue that CG178 overemphasises the use of cognitive-behavioural therapy for schizophrenia and those 'at risk' of psychosis, with recommendations that do not always reflect the evidence base. The CG178 recommendations on medications are limited.
国家卫生与保健卓越研究所(NICE)临床指南(CG)178 于 2014 年发布。NICE 指南占据着重要的国际地位。我们认为,CG178 过分强调了认知行为疗法在精神分裂症和精神病前期中的应用,其推荐意见并不总是反映证据基础。CG178 关于药物治疗的建议是有限的。